Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1975 1
1976 1
1978 1
1982 1
1985 3
1986 1
1987 1
1988 1
1989 3
1990 11
1991 6
1992 1
1993 7
1994 6
1995 6
1996 11
1997 14
1998 7
1999 15
2000 14
2001 25
2002 15
2003 29
2004 31
2005 38
2006 50
2007 50
2008 50
2009 47
2010 55
2011 70
2012 81
2013 82
2014 101
2015 150
2016 180
2017 178
2018 179
2019 170
2020 177
2021 248
2022 215
2023 225
2024 69

Text availability

Article attribute

Article type

Publication date

Search Results

2,294 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for pierre best
Search for Pierre Beust instead (1 results)
Pierre Robin Sequence.
Hsieh ST, Woo AS. Hsieh ST, et al. Clin Plast Surg. 2019 Apr;46(2):249-259. doi: 10.1016/j.cps.2018.11.010. Epub 2019 Feb 8. Clin Plast Surg. 2019. PMID: 30851756 Review.
Pierre Robin sequence consists of clinical triad of micrognathia, glossoptosis, and airway compromise with variable inclusion of cleft palate. ...Surgical management includes mandibular distraction and tongue-lip adhesion. Subglottic obstruction and central sleep apnea may …
Pierre Robin sequence consists of clinical triad of micrognathia, glossoptosis, and airway compromise with variable inclusion of clef …
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study.
Dasari A, Lonardi S, Garcia-Carbonero R, Elez E, Yoshino T, Sobrero A, Yao J, García-Alfonso P, Kocsis J, Cubillo Gracian A, Sartore-Bianchi A, Satoh T, Randrian V, Tomasek J, Chong G, Paulson AS, Masuishi T, Jones J, Csőszi T, Cremolini C, Ghiringhelli F, Shergill A, Hochster HS, Krauss J, Bassam A, Ducreux M, Elme A, Faugeras L, Kasper S, Van Cutsem E, Arnold D, Nanda S, Yang Z, Schelman WR, Kania M, Tabernero J, Eng C; FRESCO-2 Study Investigators. Dasari A, et al. Lancet. 2023 Jul 1;402(10395):41-53. doi: 10.1016/S0140-6736(23)00772-9. Epub 2023 Jun 15. Lancet. 2023. PMID: 37331369 Clinical Trial.
Eligible patients were randomly assigned (2:1) to receive fruquintinib (5 mg capsule) or matched placebo orally once daily on days 1-21 in 28-day cycles, plus best supportive care. Stratification factors were previous trifluridine-tipiracil or regorafenib, or both, RAS mut …
Eligible patients were randomly assigned (2:1) to receive fruquintinib (5 mg capsule) or matched placebo orally once daily on days 1-21 in 2 …
Diagnosis and clinical evaluation of neurogenic bladder.
Amarenco G, Sheikh Ismaël S, Chesnel C, Charlanes A, LE Breton F. Amarenco G, et al. Eur J Phys Rehabil Med. 2017 Dec;53(6):975-980. doi: 10.23736/S1973-9087.17.04992-9. Epub 2017 Oct 25. Eur J Phys Rehabil Med. 2017. PMID: 29072046 Free article. Review.
Full clinical examinations, including urodynamics and selective radiographic imaging studies, are essential to best manage these patients....
Full clinical examinations, including urodynamics and selective radiographic imaging studies, are essential to best manage these pati …
Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer.
Schettini F, Venturini S, Giuliano M, Lambertini M, Pinato DJ, Onesti CE, De Placido P, Harbeck N, Lüftner D, Denys H, Van Dam P, Arpino G, Zaman K, Mustacchi G, Gligorov J, Awada A, Campone M, Wildiers H, Gennari A, Tjan-Heijnen V, Bartsch R, Cortes J, Paris I, Martín M, De Placido S, Del Mastro L, Jerusalem G, Curigliano G, Prat A, Generali D. Schettini F, et al. Cancer Treat Rev. 2022 Dec;111:102468. doi: 10.1016/j.ctrv.2022.102468. Epub 2022 Sep 28. Cancer Treat Rev. 2022. PMID: 36202026 Free article. Review.
Trastuzumab deruxtecan in HER2-low mTNBC performed similarly and was the best advanced-line treatment in terms of PFS and OS after sacituzumab govitecan, according to SUCRA values. ...
Trastuzumab deruxtecan in HER2-low mTNBC performed similarly and was the best advanced-line treatment in terms of PFS and OS after sa …
International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations.
Meattini I, Becherini C, Caini S, Coles CE, Cortes J, Curigliano G, de Azambuja E, Isacke CM, Harbeck N, Kaidar-Person O, Marangoni E, Offersen BV, Rugo HS, Salvestrini V, Visani L, Morandi A, Lambertini M, Poortmans P, Livi L; Consensus Panellist Group. Meattini I, et al. Lancet Oncol. 2024 Feb;25(2):e73-e83. doi: 10.1016/S1470-2045(23)00534-X. Lancet Oncol. 2024. PMID: 38301705 Review.
The aim of this collaborative group of radiation, clinical, and medical oncologists, basic and translational scientists, and patient advocates was to: scope, synthesise, and summarise the literature on integrating novel drugs with radiotherapy for breast cancer; produce consensus …
The aim of this collaborative group of radiation, clinical, and medical oncologists, basic and translational scientists, and patient advocat …
Recurrent metatarsalgia.
Barouk P. Barouk P. Foot Ankle Clin. 2014 Sep;19(3):407-24. doi: 10.1016/j.fcl.2014.06.005. Epub 2014 Jul 17. Foot Ankle Clin. 2014. PMID: 25129352 Review.
Understanding etiology helps understand the mechanism of prevention, which is the best treatment. Recurrent metatarsalgia is often due to poor technique or poor understanding of the underlying problem. In hallux valgus surgery, recurrent metatarsalgia can be a problem of p …
Understanding etiology helps understand the mechanism of prevention, which is the best treatment. Recurrent metatarsalgia is often du …
L’émergence des traitements par cellules CAR-T dans les lymphomes.
Salles G, Sesques P, Ferrant E, Safar V, Ghesquieres H, Bachy E. Salles G, et al. Bull Cancer. 2018 Dec;105 Suppl 2:S168-S177. doi: 10.1016/S0007-4551(19)30047-5. Bull Cancer. 2018. PMID: 30686355 Review. French.
Tumor responses are observed in 52% to 82% of patients, with a best complete response (CR) rate of 40% to 58%. Although some patients with early CR may relapse rapidly, the quality of the response appears to improve over time for other patients in partial response, all of …
Tumor responses are observed in 52% to 82% of patients, with a best complete response (CR) rate of 40% to 58%. Although some patients …
Targeted Therapy in Advanced Melanoma With Rare BRAF Mutations.
Menzer C, Menzies AM, Carlino MS, Reijers I, Groen EJ, Eigentler T, de Groot JWB, van der Veldt AAM, Johnson DB, Meiss F, Schlaak M, Schilling B, Westgeest HM, Gutzmer R, Pföhler C, Meier F, Zimmer L, Suijkerbuijk KPM, Haalck T, Thoms KM, Herbschleb K, Leichsenring J, Menzer A, Kopp-Schneider A, Long GV, Kefford R, Enk A, Blank CU, Hassel JC. Menzer C, et al. J Clin Oncol. 2019 Nov 20;37(33):3142-3151. doi: 10.1200/JCO.19.00489. Epub 2019 Oct 3. J Clin Oncol. 2019. PMID: 31580757 Free PMC article.
CONCLUSION: Patients with rare BRAF mutations can respond to targeted therapy, however, efficacy seems to be lower compared with V600E mutated melanoma. Combination BRAFi/MEKi seems to be the best regimen for both V600 and non-V600 mutations. Yet interpretation should be d …
CONCLUSION: Patients with rare BRAF mutations can respond to targeted therapy, however, efficacy seems to be lower compared with V600E mutat …
Craniofacial syndromes.
Buchanan EP, Xue AS, Hollier LH Jr. Buchanan EP, et al. Plast Reconstr Surg. 2014 Jul;134(1):128e-153e. doi: 10.1097/PRS.0000000000000308. Plast Reconstr Surg. 2014. PMID: 25028828 Review.
Understand the most serious complications associated with each syndrome. 3. Formulate the best age-appropriate surgical plans. SUMMARY: Craniofacial syndromes fall into two major categories-those associated with craniosynostosis, and those associated with clefts. ...Operat …
Understand the most serious complications associated with each syndrome. 3. Formulate the best age-appropriate surgical plans. SUMMAR …
2,294 results